The over-expression of SOCS3 in T cells reduced IL-17 and accelerated atherosclerosis whereas the in vivo treatment with anti-sense oligodeoxynucleotides targeting SOCS3 exacerbated the atherosclerotic process in ApoE−/− mice (78). Here, IL17A is linked to atherosclerosis.